Heron Therapeutics
HRTX
HRTX
200 hedge funds and large institutions have $1.07B invested in Heron Therapeutics in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 66 increasing their positions, 57 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 197 → 200 (+3)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8% less capital invested
Capital invested by funds: $1.16B → $1.07B (-$87.7M)
Holders
200
Holding in Top 10
2
Calls
$12.5M
Puts
$10.4M
Top Buyers
| 1 | +$15M | |
| 2 | +$14.2M | |
| 3 | +$11M | |
| 4 |
Millennium Management
New York
|
+$9.17M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$9.09M |
Top Sellers
| 1 | -$17.1M | |
| 2 | -$7.16M | |
| 3 | -$7.08M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.69M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$3.69M |